FDA Application
-
NDC Search Results on Active Ingredient: methotrexate
Click on Active Ingredient to view the label.
| Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
|---|---|---|---|---|---|
| METHOTREXATE | 54436-017-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-505-00 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-510-01 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-515-01 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-020-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-020-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-010-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-012-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-510-04 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 61703-350-38 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-510-00 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-012-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-015-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-550-00 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 61703-124-40 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-515-00 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 42254-110-30 | Rebel Distributors Corp. | NDA008085 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-025-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 75840-111-00 | GenPak Solutions LLC | NDA008085 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-022-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-010-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-022-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-020-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-025-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 52652-2001-6 | Azurity Pharmaceuticals, Inc. | NDA208400 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-015-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-017-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 61703-408-41 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-515-04 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 66336-338-21 | Dispensing Solutions, Inc. | NDA008085 | HUMAN PRESCRIPTION DRUG | NDA |
| 1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-170 |
-
